Arteris (NASDAQ:AIP) Reaches New 1-Year High – What’s Next?

Shares of Arteris, Inc. (NASDAQ:AIP) reached a new 52-week high during mid-day trading on Monday . The company traded as high as $12.64 and last traded at $12.49, with a volume of 224290 shares trading hands. The stock had previously closed at $12.25.

Analyst Ratings Changes

Separately, Rosenblatt Securities reiterated a “buy” rating and set a $15.00 target price on shares of Arteris in a report on Wednesday, November 6th.

Arteris Price Performance

The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30. The stock has a market cap of $451.99 million, a PE ratio of -11.72 and a beta of 1.17. The company’s 50 day moving average is $9.08 and its 200-day moving average is $8.11.

Insider Transactions at Arteris

In other news, Director Wayne C. Cantwell sold 5,000 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $11.01, for a total value of $55,050.00. Following the completion of the sale, the director now owns 233,198 shares of the company’s stock, valued at approximately $2,567,509.98. The trade was a 2.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Nicholas B. Hawkins sold 19,299 shares of the company’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $8.14, for a total transaction of $157,093.86. Following the completion of the sale, the chief financial officer now owns 192,414 shares in the company, valued at approximately $1,566,249.96. This trade represents a 9.12 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 305,201 shares of company stock valued at $3,105,163. 33.70% of the stock is currently owned by insiders.

Institutional Trading of Arteris

Several hedge funds and other institutional investors have recently bought and sold shares of the company. US Bancorp DE bought a new position in shares of Arteris during the third quarter valued at approximately $34,000. The Manufacturers Life Insurance Company acquired a new stake in Arteris in the second quarter worth $86,000. Algert Global LLC bought a new stake in Arteris in the second quarter valued at $115,000. MetLife Investment Management LLC boosted its holdings in shares of Arteris by 129.1% during the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after acquiring an additional 9,551 shares during the period. Finally, Dynamic Technology Lab Private Ltd bought a new position in shares of Arteris during the third quarter worth about $226,000. 64.36% of the stock is owned by institutional investors.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.